Lisiena Hysenaj

Lisiena HYSENAJ, Ph.D, is a Scientist II at Parvus Therapeutics Inc, where responsibilities include designing and executing experiments in preclinical immunology and contributing to Investigational New Drug applications since October 2022. In addition to this role, Lisiena serves as Co-Chair of the Health and Life Science Committee at the French American Chamber of Commerce of San Francisco from February 2024. Prior experience includes a Scientist position at NextVivo, focusing on TIL derived from 3D tumor organoids, and a Post Doctoral Researcher role at the University of California, San Francisco, engineering organoids. Lisiena has conducted scientific outreach in Life Science and has a solid academic background with degrees from prestigious institutions, including a Ph.D. in Immunology and experience in various research settings, including internships at GlaxoSmithKline and the Stowers Institute for Medical Research.